Search research articles
Contact Us
Filters
Showing results (21-30 of 218) with videos related to
Page
of 22
Sort By:
Oncology (Williston Park, N.Y.)
|
January 4, 2018
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes
Natasha B Hunter, Samantha Vogt, Richard F Ambinder
The Lancet. Oncology
|
May 17, 2011
Use of antineoplastic agents in patients with cancer who have HIV/AIDS
Michelle A Rudek, Charles Flexner, Richard F Ambinder
Current Opinion in Oncology
|
August 23, 2002
Epstein-Barr virus DNA in body fluids
Mary Jo Lechowicz, Lan Lin, Richard F Ambinder
Current Opinion in Infectious Diseases
|
May 31, 2024
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV
Paul G Rubinstein, Carlos Galvez, Richard F Ambinder
The Lancet. HIV
|
August 14, 2020
Haemopoietic cell transplantation in patients living with HIV
Richard F Ambinder, Adam A Capoferri, Christine M Durand
Current Topics in Microbiology and Immunology
|
February 3, 2026
The Biology and Clinical Utility of EBV Monitoring in Blood
Laura F Walsh, Rena R Xian, Richard F Ambinder
Current Opinion in HIV and AIDS
|
October 28, 2010
Cancer biomarkers in HIV patients
Richard F Ambinder, Kishor Bhatia, Otoniel Martinez-Maza, et al.
Current Oncology Reports
|
June 12, 2019
Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma?
Satish Shanbhag, Nina Wagner-Johnston, Richard F Ambinder, et al.
JCO Oncology Practice
|
February 21, 2024
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients
Daniel Skoloda, Matthew Newman, Haval Norman, et al.
The American Journal of Pathology
|
May 10, 2002
Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy
Qian Tao, Jie Yang, He Huang, et al.
Page
of 22
Search research articles
Search
Showing results (21-30 of 218) with videos related to
Sort By:
Page
of 22
Oncology (Williston Park, N.Y.)
|
January 4, 2018
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes
Natasha B Hunter, Samantha Vogt, Richard F Ambinder
The Lancet. Oncology
|
May 17, 2011
Use of antineoplastic agents in patients with cancer who have HIV/AIDS
Michelle A Rudek, Charles Flexner, Richard F Ambinder
Current Opinion in Oncology
|
August 23, 2002
Epstein-Barr virus DNA in body fluids
Mary Jo Lechowicz, Lan Lin, Richard F Ambinder
Current Opinion in Infectious Diseases
|
May 31, 2024
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV
Paul G Rubinstein, Carlos Galvez, Richard F Ambinder
The Lancet. HIV
|
August 14, 2020
Haemopoietic cell transplantation in patients living with HIV
Richard F Ambinder, Adam A Capoferri, Christine M Durand
Current Topics in Microbiology and Immunology
|
February 3, 2026
The Biology and Clinical Utility of EBV Monitoring in Blood
Laura F Walsh, Rena R Xian, Richard F Ambinder
Current Opinion in HIV and AIDS
|
October 28, 2010
Cancer biomarkers in HIV patients
Richard F Ambinder, Kishor Bhatia, Otoniel Martinez-Maza, et al.
Current Oncology Reports
|
June 12, 2019
Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma?
Satish Shanbhag, Nina Wagner-Johnston, Richard F Ambinder, et al.
JCO Oncology Practice
|
February 21, 2024
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients
Daniel Skoloda, Matthew Newman, Haval Norman, et al.
The American Journal of Pathology
|
May 10, 2002
Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy
Qian Tao, Jie Yang, He Huang, et al.
Page
of 22